Latest Stories
Appendicitis
Also calledan inflamed appendix,diseased appendix,acute appendicitis,chronic appendicitis,ruptured appendix,perforated appendix, orburst appendix,appendicitis is a serious and sometimes…
Seelos Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
NEW YORK, May 12, 2020 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous…
Arbutus to Present at UBS Virtual Global Healthcare Conference
WARMINSTER, Pa., May 12, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with…
Cellulitis
What is Cellulitis?Cellulitis is a bacterial skin infection that often affects the lower legs, but it can occur anywhere in the body.What Does Cellulitis Look and Feel Like?It can appear as…
Hypothyroidism
Also called:Underactive thyroidMyxedemaHypothyroidism occurs when the thyroid gland does not produce enough hormones necessary to meet all of the body’s needs. In other words…
Catalyst Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update
Firdapse® Q1 2020 Net Revenues of $29.1 MillionFirst Quarter 2020 GAAP Net Income of $10.4 MillionCatalyst Withdraws Previous 2020 Revenue Guidance Due to COVID-19 UncertaintiesCatalyst to…
Novavax Reports First Quarter 2020 Financial Results
CEPI increases investment up to $388 million for NVX‑CoV2373 vaccine development & manufacturingNVX‑CoV2373 Phase I trial initiating in May with preliminary results in JulyNanoFlu…
Fibromyalgia
Also called:FibrositisDiffuse myofascial pain syndromeFibromyalgia myalgia syndrome (FMS)Muscular rheumatism“Fibro”Fibromyalgia is a chronic health condition that affects about 2 to 4…
Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
Funds clinical development of NVX-CoV2373 through Phase 2Supports rapid scale-up of vaccine manufacturingAllows for increased production of Matrix-M adjuvantReserves global large-scale…
Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update
Received FDA Acceptance of LIQ861 NDA for ReviewReported Final Safety and Tolerability Results for LIQ861 Inspire TrialManagement to Host Webcast and Conference Call Today at 4:30p.m…
Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series
GAITHERSBURG, Md., May 11, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases…
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Stockholders’ Equity Requirement for Continued Listing
LOS ANGELES, May 11, 2020 (GLOBE NEWSWIRE) — Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that it has received written notice…
Myriad Receives FDA Approval of myChoice CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Advanced Ovarian Cancer
SALT LAKE CITY, May 11, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced that the U.S. Food and Drug…
CytoDyn to Present at Wall Street Reporter’s NEXT SUPERSTOCK Livestream Event on May 13, 2020 at 12:30 pm ET / 9:30 am PT
VANCOUVER, Washington, May 11, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5…
Arbutus Reports First Quarter 2020 Financial Results, Provides Pipeline Update and Announces New Research Initiative to Identify Novel Antiviral Therapies for the Treatment of Coronavirus Infections
Arbutus remains on track to achieve its key 2020 objectives despite COVID-19 challengesConference Call and Webcast Scheduled Today at 8:00 AM ETWARMINSTER, Pa., May 11, 2020 (GLOBE…
Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders
NEWTOWN, Pa., May 11, 2020 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to…
Trazodone Alternatives – What Are Your Options?
Trazodone will not be the right choice for everyone. There are several different alternatives for Trazodone, therefore, you should always discuss your options with your doctor in great…
CytoDyn Clarifies Status of Biologics License Application
Additional Data Required to Complete Application Expected to be Submitted on May 11, 2020VANCOUVER, Washington, May 08, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or…
RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S.
The randomized, double-blind, placebo-controlled study aims to enroll up to 40 patients with moderate-to-severe COVID-19 pneumonia in the U.S. —All six analyzed moderate-to-severe COVID-19…
Novant Health Initiates Phase 2b/3 Trial with CytoDyn’s Leronlimab for Severely and Critically Ill COVID-19 Patients
FDA has approved 54 Emergency INDs to allow access to leronlimab for severely and critically ill COVID-19 patientsVANCOUVER, Washington and WINSTON-SALEM, N.C., May 07, 2020 (GLOBE…